These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 9740200

  • 21. Bile acid malabsorption in cystic fibrosis.
    Nutr Rev; 1974 Aug; 32(8):232-4. PubMed ID: 4602696
    [No Abstract] [Full Text] [Related]

  • 22. Comparison of a high lipase pancreatic enzyme extract with a regular pancreatin preparation in adult cystic fibrosis patients.
    Gan KH, Heijerman HG, Geus WP, Bakker W, Lamers CB.
    Aliment Pharmacol Ther; 1994 Dec; 8(6):603-7. PubMed ID: 7696449
    [Abstract] [Full Text] [Related]

  • 23. Fat absorption in cystic fibrosis mice is impeded by defective lipolysis and post-lipolytic events.
    Bijvelds MJ, Bronsveld I, Havinga R, Sinaasappel M, de Jonge HR, Verkade HJ.
    Am J Physiol Gastrointest Liver Physiol; 2005 Apr; 288(4):G646-53. PubMed ID: 15528257
    [Abstract] [Full Text] [Related]

  • 24. The effect of cimetidine on maldigestion in cystic fibrosis.
    Cox KL, Isenberg JN, Osher AB, Dooley RR.
    J Pediatr; 1979 Mar; 94(3):488-92. PubMed ID: 423042
    [Abstract] [Full Text] [Related]

  • 25. Comparison between a standard pancreatic supplement and a high enzyme preparation in cystic fibrosis.
    Morrison G, Morrison JM, Redmond AO, Byers CA, McCracken KJ, Dodge JA, Guilford SA, Bowden MW.
    Aliment Pharmacol Ther; 1992 Oct; 6(5):549-55. PubMed ID: 1420747
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Studies on the origin of faecal amino acids in cystic fibrosis.
    Seakins JW, Ersser RS, Gibbons IS.
    Gut; 1970 Jul; 11(7):600-9. PubMed ID: 5452048
    [Abstract] [Full Text] [Related]

  • 28. Steatorrhea and azotorrhea and their relation to growth and nutrition in adolescents and young adults with cystic fibrosis.
    Lapey A, Kattwinkel J, Di Sant'Agnese PA, Laster L.
    J Pediatr; 1974 Mar; 84(3):328-34. PubMed ID: 4811984
    [No Abstract] [Full Text] [Related]

  • 29. An enteric-coated high-buffered pancrelipase reduces steatorrhea in patients with cystic fibrosis: a prospective, randomized study.
    Brady MS, Garson JL, Krug SK, Kaul A, Rickard KA, Caffrey HH, Fineberg N, Balistreri WF, Stevens JC.
    J Am Diet Assoc; 2006 Aug; 106(8):1181-6. PubMed ID: 16863712
    [Abstract] [Full Text] [Related]

  • 30. Excretion of bile acids in healthy children and children with cystic fibrosis.
    Eklund A, Norman A, Strandvik B.
    Scand J Clin Lab Invest; 1980 Aug; 40(7):595-608. PubMed ID: 7466288
    [Abstract] [Full Text] [Related]

  • 31. The effect of cisapride on defaecation in normal human subjects--lack of effect on faecal excretion of water, fat, and bile acids.
    Berger V, Armbrecht U, Heusinger A, Wienbeck M, Stockbrügger R.
    Aliment Pharmacol Ther; 1989 Dec; 3(6):547-52. PubMed ID: 2518868
    [Abstract] [Full Text] [Related]

  • 32. [Digestion of fat and protein and its relation to the activity of faecal enzymes in mucoviscidosis infants under substitution therapy with pancreatic enzymes (author's transl)].
    Tolckmitt W, Lohmann A, Kutschera J.
    Klin Padiatr; 1981 Sep; 193(5):365-9. PubMed ID: 6912903
    [Abstract] [Full Text] [Related]

  • 33. Conjugated bile acids in serum and secretions in response to cholecystokinin/secretin stimulation in children with cystic fibrosis.
    Robb TA, Davidson GP, Kirubakaran C.
    Gut; 1985 Nov; 26(11):1246-56. PubMed ID: 4065698
    [Abstract] [Full Text] [Related]

  • 34. [Comparison of 2 pancreatic enzyme preparations in the treatment of digestive insufficiency in mucoviscidosis (cystic fibrosis)].
    Gottschalk B, Wiesemann HG, Stephan U.
    Monatsschr Kinderheilkd; 1988 Sep; 136(9):626-9. PubMed ID: 3237230
    [Abstract] [Full Text] [Related]

  • 35. Two enteric coated microspheres in cystic fibrosis.
    Williams J, MacDonald A, Weller PH, Fields J, Pandov H.
    Arch Dis Child; 1990 Jun; 65(6):594-7. PubMed ID: 2198848
    [Abstract] [Full Text] [Related]

  • 36. Bile acid malabsorption in cystic fibrosis with and without pancreatic insufficiency.
    Colombo C, Roda A, Roda E, Piceni Sereni L, Brega A, Fugazza R, Giunta A.
    J Pediatr Gastroenterol Nutr; 1984 Sep; 3(4):556-62. PubMed ID: 6481566
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. The management of enzymatic therapy in cystic fibrosis patients by an individualized approach.
    Costantini D, Padoan R, Curcio L, Giunta A.
    J Pediatr Gastroenterol Nutr; 1988 Sep; 7 Suppl 1():S36-9. PubMed ID: 3404360
    [Abstract] [Full Text] [Related]

  • 39. Effect of taurine supplementation on fat and energy absorption in cystic fibrosis.
    De Curtis M, Santamaria F, Ercolini P, Vittoria L, De Ritis G, Garofalo V, Ciccimarra F.
    Arch Dis Child; 1992 Sep; 67(9):1082-5. PubMed ID: 1417050
    [Abstract] [Full Text] [Related]

  • 40. The influence of long-term cimetidine as an adjuvant to pancreatic enzyme therapy in cystic fibrosis.
    Chalmers DM, Brown RC, Miller MG, Clarke PC, Kelleher J, Littlewood JM, Losowsky MS.
    Acta Paediatr Scand; 1985 Jan; 74(1):114-7. PubMed ID: 3885675
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.